Mar 4, 2026 04:06PM
Mar 4, 2026 04:01PM
Nov 5, 2025 04:58PM
Nov 5, 2025 04:01PM
Aug 6, 2025 06:13PM
Aug 6, 2025 04:21PM
Aug 6, 2025 04:15PM Keros to Exclusively Prioritize the Clinical Advancement of KER-065
Aug 6, 2025 04:01PM
May 6, 2025 04:20PM
May 6, 2025 04:01PM
Feb 26, 2025 06:37PM
Feb 26, 2025 04:01PM
Nov 6, 2024 04:01PM
Aug 7, 2024 04:01PM Keros Therapeutics Reports Second Quarter 2024 Financial Results
May 8, 2024 08:00AM
Feb 28, 2024 05:30PM
Feb 28, 2024 05:29PM
Feb 28, 2024 04:01PM
Nov 6, 2023 08:02AM
Nov 6, 2023 08:00AM
Aug 7, 2023 08:48AM Keros Therapeutics, Inc. (KROS) Tops Q2 EPS by 8c
Aug 7, 2023 08:00AM
May 4, 2023 04:54PM
May 4, 2023 04:01PM
Mar 3, 2023 04:01PM
Nov 3, 2022 07:00AM
Aug 4, 2022 04:01PM
May 5, 2022 08:00AM Keros Therapeutics Reports First Quarter 2022 Financial Results
Mar 9, 2022 04:02PM
Mar 9, 2022 04:01PM
Nov 4, 2021 09:01AM
Aug 5, 2021 04:01PM
May 6, 2021 04:01PM
Mar 25, 2021 08:00AM
Nov 10, 2020 04:17PM Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2020 Financial Results
Aug 13, 2020 12:51PM
Aug 13, 2020 07:00AM
Aug 13, 2020 07:00AM
May 22, 2020 07:00AM
May 22, 2020 07:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All